Searchable abstracts of presentations at key conferences in endocrinology

ea0094p282 | Thyroid | SFEBES2023

Thyroid eye disease in pregnant women with Graves disease: Experience from a specialized thyroid eye clinic

Dissanayake Harsha , Oustabassidis Eva , Norris Jonathan , Turner Helen

Background: Thyroid eye disease (TED) affects 25% of patients with GravesÂ’ disease (GD). GD affects nearly 1% of pregnancies. However, data on TED incidence, course, management and outcome in pregnancy are limited.Aims: To describe the prevalence, course and outcomes of TED in pregnant females.Methods: A retrospective analysis of electronic health records was conducted in a sp...

ea0090ep469 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Unmet needs in diabetic neuropathy: A cross sectional analysis from a tertiary care diabetes centre in Sri Lanka

Kobawaka Gamage Kavinga Kalhari , Athukorala T G , Dissanayake Harsha Anuruddhika , Pathmanathan Sivatharshya , Sumanatilleke Manilka , Somasundaram Noel

Background: Diabetic neuropathy, especially distal symmetric polyneuropathy (DSPN), is a common but under-recognized problem among people living with diabetes, particularly in developing countries. Aims: We aimed to describe the clinical characteristics, associated factors, treatment practices, outcomes and impact of DSPN among Sri Lankan adults living with diabetes.Methods: A cross sectional study was conducted at the Diabetes Clinic of National Hospita...

ea0086p301 | Adrenal and Cardiovascular | SFEBES2022

Feasibility of primary aldosteronism screening in primary care – prevalence and concordance with secondary care assessment

Marie Hannon Anne , Dissanayake Harsha , Warner Bronwen , Mihai Radu , James Tim , Ray David , Shine Brian , Pal Aparna

Background: Primary aldosteronism (PA) is the commonest cause of secondary hypertension. Reported prevalence is about 30% in hypertensive population. Success of screening for PA in general practice (GP) is unknown. Expected challenges include laboratory access, transport issues and interfering medications.Aims: We aimed to report prevalence of PA in a large primary care cohort, the correlation between GP and in-hospital ARR and to assess if a change in r...

ea0090p454 | Reproductive and Developmental Endocrinology | ECE2023

Effect of selective oestrogen receptor modulators/aromatase inhibitors on semen parameters in men with secondary hypogonadism; systematic review and meta-analysis

Lakshitha de Silva Nipun , Dissanayake Harsha , Suarez Camila , Wickramarachchi R. E. , Ramasamy Ranjith , Dhillo Waljit , Minhas Suks , Corona Giovanni , Jayasena Channa

Introduction: Selective oestrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) potentially increase endogenous gonadotrophin and testosterone secretion in men. They are used off-label in men with hypogonadism and/or infertility. There is a lack of guidance on using these agents in men with secondary hypogonadism, though these agents are widely used in these people as a cheaper alternative to gonadotrophins. Methods: Systematic search was co...